$ANVS
Annovis Bio, Inc.
NYSE · Healthcare · Pharmaceutical Preparations · Malvern, PA
ANVS chart
What traders are saying about $ANVS
Latest postsAnnovis Bio, Inc. news
- Annovis Announces Closing of $21.0 Million Public Offering with 24% Contribution from the Board Chairman
Yahoo Finance ·
- Bullish Annovis Bio Insider Buying Worth US$7.10m Yet To Pay Off
Simply Wall St ·
- Director Michael B. Hoffman Acquires 5 Million Shares and Warrants of Annovis Bio at $1 Each on November 6, 2026
Kalkine Media ·
- Annovis Bio Director Purchased Shares Worth Over $5M
TradingView ·
- A director buys Annovis Bio (ANVS) shares with warrants carrying a $1 exercise price.
Stock Titan ·
- Form 8K Annovis Bio Inc For: 5 November By Investing.com
Investing.com Nigeria ·
- Annovis Bio Announces Pricing of Public Offering and Underwriting Agreement
TipRanks ·
- Annovis Bio Prices $21 Million Public Offering to Fund Buntanetap Clinical Development
TradingView ·
- A director agrees to buy about $5M of Annovis Bio (NYSE: ANVS) shares and accompanying warrants.
Stock Titan ·
- InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Proposed Public Offering to Support Buntanetap Clinical Development
StreetInsider ·
- Cash-strapped Annovis Bio files to raise $21M as stock price sinks
The Business Journals ·
- Annovis Bio prices $21M public offering; shares slump
TradingView ·
Annovis Bio, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net income | -$28.9M | -$24.6M | -$56.2M | -$25.3M |
| Diluted EPS | $-1.40 | $-2.31 | $-6.23 | $-3.10 |
| Total assets (year end) | $21.1M | $13.9M | $10.2M | $36.0M |
| Cash and equivalents (year end) | $19.5M | $10.6M | $5.8M | $28.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Annovis Bio, Inc.
- Ticker
- ANVS (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Malvern, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1477845
- Former names
- QR Pharma, Inc.
Frequently asked questions
What exchange is Annovis Bio, Inc. listed on?
Annovis Bio, Inc. trades on the NYSE under the ticker symbol ANVS.
What industry is Annovis Bio, Inc. in?
Annovis Bio, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Annovis Bio, Inc. headquartered?
Annovis Bio, Inc.'s business address on file with the SEC is in Malvern, PA.
When does Annovis Bio, Inc.'s fiscal year end?
Annovis Bio, Inc.'s fiscal year ends on December 31.
How much revenue did Annovis Bio, Inc. report?
Annovis Bio, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.